Cargando…

FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance

Detalles Bibliográficos
Autores principales:	Millour, J, Lam, EW
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875564/ http://dx.doi.org/10.1186/bcr2499

Ejemplares similares

FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
por: Millour, Julie, et al.
Publicado: (2010)

Hypoxia and ERα Transcriptional Crosstalk Is Associated with Endocrine Resistance in Breast Cancer
por: Jehanno, Charly, et al.
Publicado: (2022)

Analysis of survivin, XIAP and FoxM1 as potential chemoresistance factors in breast cancer cells
por: Moraes, Gabriela N, et al.
Publicado: (2013)

HER2 and ERβ2 downregulate estrogen-responsive element-mediated transcription activity of ERα-positive cells in response to estrogen stimulation
por: Park, B-W, et al.
Publicado: (2005)

Polymorphisms of estrogen receptors, ERα and GPR30: association with breast cancer susceptibility and prognosis
por: Alves, Susana M, et al.
Publicado: (2010)

Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer
por: Løkkegaard, S, et al.
Publicado: (2011)

Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
por: Ziegler, Yvonne, et al.
Publicado: (2021)

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines
por: Ehlers, Natasja S, et al.
Publicado: (2012)

Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010)

Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer
por: Fox, Emily M., et al.
Publicado: (2012)

Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis
por: Xu, Tong, et al.
Publicado: (2022)

Procalcitonin has a poor prognosis value in critically ill patients with candidemia
por: Charles, PE, et al.
Publicado: (2012)

Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER(+) Breast Cancer
por: Ros, Susana, et al.
Publicado: (2020)

AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance
por: Ng, Angel S.N., et al.
Publicado: (2022)

MicroRNA-92 targets the 3' untranslated region of ERβ1 mRNA and post-transcriptionally regulates its expression in breast cancer
por: Alnakhle, HH, et al.
Publicado: (2010)

Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells
por: Opyrchal, Mateusz, et al.
Publicado: (2014)

ECM1 is associated with endocrine resistance in ER(+) breast cancers
por: Lee, Tae Won, et al.
Publicado: (2022)

ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
por: Strillacci, Antonio, et al.
Publicado: (2022)

The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
por: Bergamaschi, Anna, et al.
Publicado: (2014)

JMJD6 orchestrates a transcriptional program in favor of endocrine resistance in ER+ breast cancer cells
por: Das, Partha, et al.
Publicado: (2022)

Developmental protein HOXC11 cooperates with SRC-1 in breast cancer: an adaptive response to endocrine therapy
por: McIlroy, M, et al.
Publicado: (2010)

The viral Tat protein has no essential function in HIV-1 replication other than to activate transcription
por: Das, Atze T, et al.
Publicado: (2009)

Endocrine responses to major abdominal surgery
por: Dimopoulou, I, et al.
Publicado: (2005)

Endocrine complications in patients with thalassaemia major
por: Meng, Zhe, et al.
Publicado: (2013)

Endocrine complications in survivors of childhood medulloblastoma
por: Yuet-ling, Joanna Tung, et al.
Publicado: (2015)

Assessment clinics at 'Avon Breast Screening Unit': what has changed in 5 years?
por: Chakrabarthi, S, et al.
Publicado: (2004)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

High-grade ER-negative tumour breast cancers are characteristic of both very young onset cases and patients with hereditary breast cancer
por: Eccles, D, et al.
Publicado: (2006)

Single point measurement of cystatin C has similar performance as serum creatinine for assessment of kidney function in critically ill patients
por: Houthoofd, J, et al.
Publicado: (2015)

Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer
por: Imbert-Fernandez, Yoannis, et al.
Publicado: (2014)

ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation
por: Huggins, Rosemary J., et al.
Publicado: (2023)

Variability of insulin sensitivity during the first 4 days of critical illness
por: Pretty, C, et al.
Publicado: (2012)

Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2− Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2− Breast Cancer
por: Roßwag, Sven, et al.
Publicado: (2021)

Completion of 5-year adjuvant endocrine therapy in the community
por: Makubate, B, et al.
Publicado: (2010)

Roles of endocrine FGF signaling in metabolic health and cancer
por: Luo, Yongde, et al.
Publicado: (2014)

Imaging diagnostic standard in multiple endocrine neoplasia (MEN)
por: Tesdorff, J, et al.
Publicado: (2014)

Severe aortic stenosis with high valvulo-arterial impedance (Zva) has more adverse cardiac changes on cardiovascular magnetic resonance
por: Lam, Willis, et al.
Publicado: (2016)

The effect of age and breast density on the sensitivity of mammography
por: Kavanagh, AM, et al.
Publicado: (2004)

FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c
por: Lam, Andy K. Y., et al.
Publicado: (2013)

Tomato supernatant in a microenvironment has the proliferative and antiproliferarive opposing effects on breast cancer and fetal cultured cells
por: Mejsnar, Jiri A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_easlg8ni4rt3srj3t747j1g8m3